Carrie McAdams MD PhD
@cjmcadams.bsky.social
Neuroscientist and Psychiatrist - interested in Mechanisms & Targets to improve treatments for people with eating disorders.
Reposted by Carrie McAdams MD PhD
No more anti-depressants, anxiolytics, ADHD medications, or GLP-1 agonists (Ozempic, Mounjaro, etc) for anyone! Unclear if that last category would also apply to treating type 2 diabetes, which is also a chronic disease.
February 14, 2025 at 1:21 AM
No more anti-depressants, anxiolytics, ADHD medications, or GLP-1 agonists (Ozempic, Mounjaro, etc) for anyone! Unclear if that last category would also apply to treating type 2 diabetes, which is also a chronic disease.
Definitely logs.
January 14, 2025 at 4:20 AM
Definitely logs.
Reposted by Carrie McAdams MD PhD
Mentoring schemes to ‘fix the women’, unhelpful stereotyping, and cookie cutter approach to diversity (usually centering white women) are and will always be ineffective. They don’t help minoritised & marginalised women. They also don’t help mainstream white, cishet, able bodied women either. /12
December 1, 2024 at 4:59 AM
Mentoring schemes to ‘fix the women’, unhelpful stereotyping, and cookie cutter approach to diversity (usually centering white women) are and will always be ineffective. They don’t help minoritised & marginalised women. They also don’t help mainstream white, cishet, able bodied women either. /12